These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17805535)

  • 1. Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion.
    Chao MM; Kontny U; Brink I; Göhring G; Schmitt-Gräff A; Rister M; Strahm B
    Ann Hematol; 2008 Feb; 87(2):165-6. PubMed ID: 17805535
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
    Gassas A; Sung L; Saunders EF; Doyle J
    Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
    Loren AW; Porter DL
    Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of acute lymphoblastic leukemia in the breast after allogeneic stem cell transplantation and concomitant persistence of donor hematopoiesis.
    Manna A; Magli T
    Haematologica; 2001 Jul; 86(7):767-8. PubMed ID: 11454536
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
    Tagliabue A; Corti P; Viganò E; Bonanomi S; Uderzo C
    Bone Marrow Transplant; 2005 Sep; 36(5):459. PubMed ID: 15980883
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
    Bader P; Dückers G; Kreyenberg H; Hoelle W; Kerst G; Lang P; Greil J; Niethammer D; Beck LF; Klingebiel T
    Ann Hematol; 2002; 81 Suppl 2():S25-7. PubMed ID: 12611064
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor cell-derived leukemia and myelodysplastic neoplasm: unique forms of leukemia.
    Sala Torra O; Loeb KR
    Am J Clin Pathol; 2011 Apr; 135(4):501-4. PubMed ID: 21411772
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized vitiligo after allogeneic bone marrow transplantation.
    Cho SB; Roh MR; Chung KY; Lee KH; Park YK
    Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.
    Sockel K; Ehninger G; Hofbauer LC; Platzbecker U
    Expert Rev Hematol; 2011 Dec; 4(6):669-80. PubMed ID: 22077530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
    Davies JK; Taussig DC; Oakervee H; Davies AJ; Agrawal SG; Gribben JG; Lister TA; Cavenagh JD
    J Clin Oncol; 2006 May; 24(14):e23-5. PubMed ID: 16682729
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
    Shaw BE; Russell NH
    Bone Marrow Transplant; 2008 Mar; 41(5):495-503. PubMed ID: 17952130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor cell-derived myelodysplastic syndrome after cord blood transplantation.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Hongo E; Uchimaru K; Tojo A; Asano S
    Bone Marrow Transplant; 2009 Mar; 43(5):429-31. PubMed ID: 18978827
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans.
    Chadwick C; Marven SM; Vora AJ
    Bone Marrow Transplant; 2004 Feb; 33(4):451-3. PubMed ID: 14716352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.
    Roos-Weil D; Nguyen S; Uzunov M; Bories D; Chapiro E; Nguyen-Khac F; Vernant JP; Dhédin N
    Bone Marrow Transplant; 2010 Sep; 45(9):1471-3. PubMed ID: 20098458
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation for myelodysplastic syndrome.
    Barrett AJ; Savani BN
    Semin Hematol; 2008 Jan; 45(1):49-59. PubMed ID: 18179969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.